Pfizer, Allergan Call Off Merger After ‘Inversion’ Tax Rule Change
NEW YORK — Pfizer Inc. on April 6 said it and Allergan PLC have agreed to terminate their November merger agreement “as a result of the occurrence of an adverse tax...To view the full article, register now.
Already a subscriber? Click here to view full article